58m
BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100
BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by carbapenem-resistant ...
The Goose Hollow Inn is exactly that kind of place, a humble tavern that’s been quietly perfecting the art of the Reuben ...
US President Donald Trump said Monday the American military had begun a blockade of Iranian ports as part of his effort to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results